首页 > 市场调查报告书 > 製药

癌症生物製剂

市场调查报告书

商品编码

1609744

2024-2032 年日本癌症免疫治疗市场报告（按治疗类型、应用、最终用户和地区）

Japan Cancer Immunotherapy Market Report by Therapy Type, Application, End User, and Region 2024-2032

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2023年日本癌症免疫治疗市场规模达70.151IMARC Group美元。该市场受到几个重要因素的推动，包括癌症发病率的增加、政府的支持计划以及医疗保险的广泛普及。

癌症是一种疾病，其特征是体内某些细胞不受控制地生长和扩散到各个部位。它的发展通常与饮酒或吸烟、不健康饮食、空气污染和缺乏体力活动等因素有关。受癌症影响的人可能会经历重大的健康挑战，包括焦虑、忧郁、对死亡的恐惧、疼痛、压力，甚至自杀的想法。免疫疗法是一种癌症治疗方法，涉及使用与癌细胞产生的蛋白质结合併抑制其活性的抗体。这种方法有助于增强免疫系统识别和消除体内异常癌细胞的能力。因此，它广泛应用于治疗各种癌症类型，包括肺癌、乳腺癌、大肠直肠癌、黑色素瘤、前列腺癌、头颈癌、甲状腺癌、肾癌、肝癌、子宫颈癌、膀胱癌、卵巢癌和皮肤癌。

日本癌症免疫治疗市场趋势：

在日本市场的背景下，几个重要因素正在对癌症免疫治疗领域产生正面影响。主要驱动因素之一是癌症病例数量不断增加，这是由于全世界个人不良的饮食习惯和接触有害物质所造成的。此外，全球人口对多样化癌症治疗选择的认识不断增强，这有助于市场扩张。此外，与传统抗肿瘤疗法相比，癌症免疫疗法能够提供更长的无恶化存活期（PFS）和总存活期（OS），这推动了癌症免疫疗法的越来越多的采用。医疗保险的可用性和可及性，以及医疗保健支出的不断增加，为行业投资者带来了诱人的成长前景。此外，对副作用较小的治疗方法的需求不断增长，这与新型免疫疗法的批准不断增加相一致，并推动了市场成长。各国政府机构和非营利组织正在透过广泛的以癌症预防为重点的宣传活动，积极推动癌症免疫疗法的采用。最后，市场受益于癌症治疗疗法的持续技术进步，这提高了疾病管理策略的效率。这些因素共同促进了日本癌症免疫治疗市场的正向成长轨迹。

日本癌症免疫治疗市场细分：

治疗类型见解：

单株抗体
癌症疫苗
检查点抑制剂
免疫调节剂
其他的

应用见解：

肺癌
乳癌
大肠直肠癌
黑色素瘤
摄护腺癌
头颈癌
其他的

最终使用者见解：

医院
癌症研究中心
诊所
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

到目前为止，日本癌症免疫治疗市场的表现如何，未来几年将如何表现？
COVID-19 对日本癌症免疫治疗市场有何影响？
日本癌症免疫治疗市场依治疗类型划分是怎样的？
日本癌症免疫治疗市场的应用现况如何？
日本癌症免疫治疗市场的最终用户细分情况如何？
日本癌症免疫治疗市场价值链的各个阶段是什么？
日本癌症免疫治疗的关键驱动因素和挑战是什么？
日本癌症免疫治疗市场的结构如何？
日本癌症免疫治疗市场的竞争程度如何？

本报告回答的关键问题：

日本癌症免疫治疗市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本癌症免疫治疗市场有何影响？
日本癌症免疫治疗市场依治疗类型划分是怎样的？
日本癌症免疫治疗市场的应用现况如何？
日本癌症免疫治疗市场的最终用户细分情况如何？
日本癌症免疫治疗市场价值链的各个阶段是什么？
日本癌症免疫治疗的关键驱动因素和挑战是什么？
日本癌症免疫治疗市场的结构如何？
日本癌症免疫治疗市场的竞争程度如何？

单株抗体
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
癌症疫苗
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
检查点抑制剂
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
免疫调节剂
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
其他的
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）

第 7 章：日本癌症免疫治疗市场 - 细分：按应用分类

肺癌
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
乳癌
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
大肠直肠癌
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
黑色素瘤
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
摄护腺癌
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
头颈癌
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
其他的
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）

第 8 章：日本癌症免疫治疗市场 - 细分：按最终用户划分

医院
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
癌症研究中心
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
诊所
- 概述
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）
其他的
- 历史与当前市场趋势（2018-2023）
- 市场预测（2024-2032）

第 9 章：日本癌症免疫治疗市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 10 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 11 章：日本癌症免疫治疗市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 12 章：附录

简介目录

Product Code: SR112024A18570

Japan cancer immunotherapy market size reached US$ 7,015.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13,635.7 Million by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. The market is being propelled by several significant factors, including an increasing incidence of cancer cases, supportive government programs, and the widespread accessibility of medical insurance.

Cancer is a medical condition characterized by the uncontrolled growth and spread of certain cells in the body to various parts. Its development is often linked to factors such as alcohol or tobacco consumption, an unhealthy diet, exposure to air pollution, and a lack of physical activity. Individuals affected by cancer can experience significant health challenges, including feelings of anxiety, depression, fear of mortality, pain, stress, and even thoughts of suicide. Immunotherapy is an approach to cancer treatment involving the use of antibodies that bind to and inhibit the activity of proteins produced by cancer cells. This method helps strengthen the immune system's ability to identify and eliminate abnormal cancer cells within the body. Consequently, it finds widespread application in the treatment of various cancer types, including lung, breast, colorectal, melanoma, prostate, head and neck, thyroid, kidney, liver, cervical, bladder, ovarian, and skin cancers.

Japan Cancer Immunotherapy Market Trends:

In the context of the Japanese market, several significant factors are positively impacting the cancer immunotherapy sector. One of the primary drivers is the rising number of cancer cases, attributed to poor dietary habits and exposure to harmful substances among individuals worldwide. Additionally, there is a growing awareness regarding diverse cancer treatment options among the global population, contributing to market expansion. Furthermore, the increasing adoption of cancer immunotherapies is driven by their ability to offer prolonged progression-free survival (PFS) and overall survival (OS) compared to traditional anti-tumor therapies. The availability and accessibility of medical insurance, alongside rising healthcare expenditure, are presenting attractive growth prospects for industry investors. Moreover, there is a growing demand for treatment approaches with fewer adverse effects, which aligns with the increasing approval of novel immunotherapies and fuels market growth. Government agencies and non-profit organizations in various countries are actively promoting the adoption of cancer immunotherapy through widespread awareness campaigns focused on cancer prevention. Lastly, the market benefits from ongoing technological advancements in cancer treatment therapies, which are enhancing the efficiency of disease management strategies. These factors collectively contribute to the positive growth trajectory of the cancer immunotherapy market in Japan.

Japan Cancer Immunotherapy Market Segmentation:

Therapy Type Insights:

Monoclonal Antibodies
Cancer Vaccines
Checkpoint Inhibitors
Immunomodulators
Others

Application Insights:

Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Head and Neck Cancer
Others

End User Insights:

Hospitals
Cancer Research Centers
Clinics
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan cancer immunotherapy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan cancer immunotherapy market?
What is the breakup of the Japan cancer immunotherapy market on the basis of therapy type?
What is the breakup of the Japan cancer immunotherapy market on the basis of application?
What is the breakup of the Japan cancer immunotherapy market on the basis of end user?
What are the various stages in the value chain of the Japan cancer immunotherapy market?
What are the key driving factors and challenges in the Japan cancer immunotherapy?
What is the structure of the Japan cancer immunotherapy market and who are the key players?
What is the degree of competition in the Japan cancer immunotherapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cancer Immunotherapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cancer Immunotherapy Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Cancer Immunotherapy Market - Breakup by Therapy Type

6.1 Monoclonal Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Forecast (2024-2032)
6.2 Cancer Vaccines
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
6.3 Checkpoint Inhibitors
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)
6.4 Immunomodulators
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2018-2023)
- 6.4.3 Market Forecast (2024-2032)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2018-2023)
- 6.5.2 Market Forecast (2024-2032)

7 Japan Cancer Immunotherapy Market - Breakup by Application

7.1 Lung Cancer
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 Breast Cancer
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)
7.3 Colorectal Cancer
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2018-2023)
- 7.3.3 Market Forecast (2024-2032)
7.4 Melanoma
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2018-2023)
- 7.4.3 Market Forecast (2024-2032)
7.5 Prostate Cancer
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2018-2023)
- 7.5.3 Market Forecast (2024-2032)
7.6 Head and Neck Cancer
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2018-2023)
- 7.6.3 Market Forecast (2024-2032)
7.7 Others
- 7.7.1 Historical and Current Market Trends (2018-2023)
- 7.7.2 Market Forecast (2024-2032)

8 Japan Cancer Immunotherapy Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
8.2 Cancer Research Centers
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
8.3 Clinics
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2018-2023)
- 8.3.3 Market Forecast (2024-2032)
8.4 Others
- 8.4.1 Historical and Current Market Trends (2018-2023)
- 8.4.2 Market Forecast (2024-2032)

9 Japan Cancer Immunotherapy Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Cancer Immunotherapy Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis